# Verified Hypotheses

## 1. SQLE Negatively Regulates Mitochondrial Mass

**Date:** 2024
**Confidence:** 85/100
**Novelty:** 90/100

## 2. pH Dysregulation as Convergent Mechanism in Renal Cell Carcinoma

**Date:** December 2024
**Confidence:** 78/100
**Novelty:** 75/100


## 3. NXF1 Knockout Causes Severe Cell Death: Essential Gene Validation

**Date:** December 2024
**Confidence:** 95/100
**Novelty:** 25/100


## 4. Fanconi Anemia Pathway Disruption Causes Mitochondrial Dysfunction via RAD51 Bridge Mechanism

**Date:** December 2024
**Confidence:** 82/100
**Novelty:** 80/100


## 7. CUL3 Knockout Causes ER Stress and Cytoskeletal Disruption: Implications for Kidney Cancer Prognosis

**Date:** December 2024
**Confidence:** 82/100
**Novelty:** 75/100

## 6. LONP1 Knockout Causes Severe Mitochondrial Dysfunction: CODAS Syndrome Cellular Phenotype

**Date:** December 2024
**Confidence:** 88/100
**Novelty:** 70/100


## 5. Lysosomal Storage Disease Genes Induce ER Stress and Organelle Remodeling

**Date:** December 2024
**Confidence:** 78/100
**Novelty:** 75/100


## 6. VCP Knockout Induces ER Stress-Mediated RNA Processing Defects

**Date:** December 2, 2025
**Confidence:** 100/100
**Novelty:** 75/100

## 7. Proteasome Dysfunction Induces ER Stress: A Morphological Link to Autoinflammatory Disease

**Date:** December 2024
**Confidence:** 82/100
**Novelty:** 78/100

## 8. LONP1 Knockout Causes Severe Mitochondrial Dysfunction: CODAS Syndrome Cellular Phenotype

**Date:** December 2024
**Confidence:** 88/100
**Novelty:** 70/100

## 9. CUL3 Knockout Causes ER Stress and Cytoskeletal Disruption: Implications for Kidney Cancer Prognosis

**Date:** December 2024
**Confidence:** 82/100
**Novelty:** 75/100

## 10. GCH1 Knockout Reveals BH4-Dependent Mitochondrial Dysfunction: A Novel Morphological Link to Cardiovascular Disease Risk

**Date:** December 2, 2025
**Confidence:** 100/100
**Novelty:** 75/100
**Gene:** GCH1 (GTP Cyclohydrolase 1)
**Disease Connection:** Cardiovascular disease (hypertension, atherosclerosis, endothelial dysfunction), Dopa-responsive dystonia, Phenylketonuria

## 11. ATP6V1G1 Knockout Reveals Novel Nucleolar Dysfunction: Linking V-ATPase to Ribosome Biogenesis and Renal Cancer

**Date:** December 2, 2025
**Confidence:** 75/100
**Novelty:** 85/100
**Gene:** ATP6V1G1 (V-ATPase G1 subunit)
**Disease Connection:** Renal Cell Carcinoma (KIRC) - prognostic marker (high expression = better survival)

## 12. GSTM3 Knockout Reveals Mitochondrial Depletion and Oxidative Stress Vulnerability: A Novel Link to Glutathione-Dependent Mitochondrial Homeostasis

**Date:** December 2, 2025
**Confidence:** 82/100
**Novelty:** 85/100
**Gene:** GSTM3 (Glutathione S-Transferase Mu 3)
**Disease Connection:** Hepatocellular Carcinoma, Glioblastoma, Neurodegenerative Diseases, Cardiovascular Disease, Intrahepatic Cholestasis

## 13. FDPS Perturbation Causes Bidirectional Organelle Stress: ER Stress in Knockout, Mitochondrial Dysfunction in Overexpression

**Date:** December 2, 2024
**Confidence:** 85/100
**Novelty:** 85/100
**Gene:** FDPS (Farnesyl Diphosphate Synthase)
**Disease Connection:** Porokeratosis (POROK9 - autosomal dominant skin disease), Osteoporosis (bisphosphonate target), Cancer (oncogenic overexpression)

## 14. Aminoacyl-tRNA Synthetase Deficiency Reveals Conserved Mitochondrial Morphological Signature Linking Translation Fidelity to Neurological Disease

**Date:** December 2024
**Confidence:** 82/100
**Novelty:** 85/100
**Genes:** KARS, HARS, NARS, FARSA, FARSB, EPRS, SARS (7 aminoacyl-tRNA synthetases)
**Disease Connection:** Charcot-Marie-Tooth Disease (CMT) - KARS (CMTRIB), HARS (CMT2W + Usher Syndrome IIIB), GARS (CMT2D), AARS (CMT2N), YARS (CMT1C)

## 15. ESPL1 Knockout Induces Polyploidy with Dramatic Cellular Enlargement and Mitochondrial Depletion: A Novel Morphological Signature of Separase Deficiency

**Date:** December 3, 2024
**Confidence:** 88/100
**Novelty:** 90/100
**Gene:** ESPL1 (Extra Spindle Pole Bodies Like 1, Separase)
**Disease Connection:** Cancer (aneuploidy, chromosomal instability), Mosaic Variegated Aneuploidy syndrome, Aging (polyploidy accumulation), Infertility (meiotic defects)

## 16. GFM1 Knockout Causes Severe Mitochondrial Dysfunction: Morphological Signature of Combined Oxidative Phosphorylation Deficiency

**Date:** December 3, 2025
**Confidence:** 88/100
**Novelty:** 82/100
**Gene:** GFM1 (G elongation factor mitochondrial 1)
**Disease Connection:** Combined Oxidative Phosphorylation Deficiency 1 (COXPD1), Neonatal mitochondrial hepatoencephalopathy, Mitochondrial translation defects

## 17. ZNF804A Knockout Reveals Novel Link Between Psychiatric Risk Gene and Cellular Apoptosis

**Date:** December 3, 2025
**Confidence:** 85/100
**Novelty:** 75/100
**Gene:** ZNF804A (Zinc Finger Protein 804A)
**Disease Connection:** Schizophrenia (rs1344706 SNP), Bipolar Disorder, Heroin Addiction, Glioblastoma (prognostic marker)

## 18. BIRC5 Knockout Induces Mitotic Catastrophe and Apoptosis: Multi-Modal Validation of Cancer Therapeutic Target

**Date:** December 3, 2024
**Confidence:** 88/100
**Novelty:** 75/100
**Gene:** BIRC5 (Baculoviral IAP Repeat Containing 5, Survivin)
**Disease Connection:** Multiple cancers (kidney, liver, lung, breast, ovarian, colorectal, glioblastoma) - prognostic marker (unfavorable)

## 19. ZBTB20 Knockout Induces Cytoplasmic DNA Accumulation and DNA Damage: A Cellular Mechanism Underlying Primrose Syndrome

**Date:** December 11, 2024
**Confidence:** 82/100
**Novelty:** 85/100
**Gene:** ZBTB20 (Zinc Finger and BTB Domain Containing 20)
**Disease Connection:** Primrose Syndrome (OMIM: 259050) - macrocephaly, intellectual disability, calcified pinnae, dysmorphic features

## 19. Interferon Pathway Overexpression Causes Systematic Mitochondrial Dysfunction: A Novel Mechanism Linking Chronic Interferon Signaling to Autoimmune Disease Pathology

**Date:** December 11, 2025
**Confidence:** 85/100
**Novelty:** 82/100
**Genes:** IFIH1/MDA5, JAK1, JAK2, STAT1, STAT2, IRF1, IRF7, IRF9 (entire interferon signaling pathway)
**Disease Connection:** Aicardi-Goutières Syndrome (AGS), Type 1 Diabetes, Singleton-Merten Syndrome, Multiple Sclerosis, Systemic Lupus Erythematosus

## 20. CA4 Knockout Causes Mitochondrial Dysfunction via pH Dysregulation: Novel Cellular Mechanism of Renal Tubular Acidosis

**Date:** December 10, 2024
**Confidence:** 88/100
**Novelty:** 85/100
**Gene:** CA4 (Carbonic Anhydrase 4)
**Disease Connection:** Renal Tubular Acidosis (RTA), Retinitis Pigmentosa, Cancer (breast, kidney, rectum, brain, liver, prostate), Autoimmune diseases (SLE, Sjögren's syndrome)

## 21. Peroxisome Dysfunction Reveals Distinct Organellar Crosstalk Mechanisms: PEX1/PEX6 Drive Mitochondrial Stress, PEX10 Drives ER Stress

**Date:** December 10, 2025
**Confidence:** 82/100
**Novelty:** 85/100
**Genes:** PEX1, PEX6, PEX10, PEX13 (Peroxisome biogenesis factors)
**Disease Connection:** Zellweger Syndrome Spectrum Disorders (ZSSD), Neonatal Adrenoleukodystrophy, Heimler Syndrome, Peroxisome Biogenesis Disorders

## 22. PTCH1 Knockout Induces Dramatic Mitochondrial Network Expansion: A Novel Link Between Hedgehog Signaling and Mitochondrial Biogenesis

**Date:** December 10, 2024
**Confidence:** 96/100
**Novelty:** 90/100
**Gene:** PTCH1 (Patched 1)
**Disease Connection:** Basal Cell Carcinoma (most common cancer), Medulloblastoma, Gorlin Syndrome, Holoprosencephaly

## 23. EIF4A3 and the Exon Junction Complex: A Critical Link Between RNA Processing Defects and Richieri-Costa-Pereira Syndrome

**Date:** December 3, 2024
**Confidence:** 88/100
**Novelty:** 75/100
**Gene:** EIF4A3 (Eukaryotic Initiation Factor 4A3)
**Disease Connection:** Richieri-Costa-Pereira Syndrome (RCPS - rare genetic disorder with microcephaly, craniofacial abnormalities, limb defects), Multiple cancers (bladder, lung, liver, kidney - prognostic marker)

## 24. SOD1 Morphological Phenotypes Reveal Novel ALS-Parkinson's Disease Connection Through GBA Similarity

**Date:** December 10, 2024
**Confidence:** 72/100
**Novelty:** 85/100
**Gene:** SOD1 (Superoxide Dismutase 1)
**Disease Connection:** Amyotrophic Lateral Sclerosis (ALS - 20% of familial cases), Novel connection to Parkinson's Disease through GBA morphological similarity

## 25. PHB2 Perturbation Reveals Bidirectional Mitochondrial Dysfunction: Knockout Increases Mitochondrial Mass, Overexpression Causes Catastrophic Depletion

**Date:** December 10, 2024
**Confidence:** 92/100
**Novelty:** 88/100
**Gene:** PHB2 (Prohibitin 2)
**Disease Connection:** Diabetic Kidney Disease, Cardiorenal Syndrome, Mitochondrial Diseases


## 26. PARK2 Knockout Induces ER Stress and Cytoskeletal Remodeling: A Novel Link Between Mitophagy Deficiency and Cellular Architecture

**Date:** December 2024
**Confidence:** 82/100
**Novelty:** 78/100
**Gene:** PARK2 (Parkin RBR E3 Ubiquitin Protein Ligase)
**Disease Connection:** Parkinson's Disease (autosomal recessive juvenile Parkinsonism, early-onset PD - 50% of familial cases)


## 27. C1GALT1 Knockout Induces ER Expansion and Stress: Morphological Signature of O-Glycosylation Deficiency Linking Tn Syndrome to Cancer Progression

**Date:** December 10, 2024
**Confidence:** 85/100
**Novelty:** 88/100
**Gene:** C1GALT1 (Core 1 β1,3-galactosyltransferase 1)
**Disease Connection:** Tn Syndrome (rare blood disorder), IgA Nephropathy, Multiple Cancers (colorectal, pancreatic, gastric, breast) - prognostic marker

## 28. NLRC5 Knockout Induces Cellular Senescence and Proliferation Defect: A Novel Tumor Suppressor Mechanism Beyond MHC-I Regulation

**Date:** December 2024
**Confidence:** 85/100
**Novelty:** 85/100
**Gene:** NLRC5 (NOD-Like Receptor Family CARD Domain Containing 5)
**Disease Connection:** Autoimmune diseases (Rheumatoid Arthritis, Inflammatory Bowel Disease), Cancer (Pancreatic adenocarcinoma prognostic marker), Inflammatory disorders

## 29. IRF3 Knockout Reveals Paradoxical Mitochondrial Accumulation: A Novel Non-Canonical Function Beyond Apoptosis

**Date:** December 10, 2025
**Confidence:** 88/100
**Novelty:** 85/100
**Gene:** IRF3 (Interferon Regulatory Factor 3)
**Disease Connection:** Viral infections, Autoimmune diseases (Aicardi-Goutières syndrome, SAVI), Myocardial infarction, Ischemia-reperfusion injury

## 30. DNA Replication Catastrophe: POLA1 Knockout Induces Granular Chromatin and Replication Stress

**Date:** December 10, 2025
**Confidence:** 92/100
**Novelty:** 88/100
**Gene:** POLA1 (DNA Polymerase Alpha 1, Catalytic Subunit)
**Disease Connection:** X-linked Reticulate Pigmentary Disorder (H02484), Meier-Gorlin Syndrome (H01889), X-linked Syndromic Intellectual Developmental Disorder (H00658), Cancer (liver, lung)

## 31. SIRT6 Overexpression Induces Mitochondrial Biogenesis and Metabolic Reprogramming: A Novel Morphological Link to Longevity and Aging

**Date:** December 11, 2025
**Confidence:** 88/100
**Novelty:** 85/100
**Gene:** SIRT6 (Sirtuin 6, NAD-dependent protein deacetylase)
**Disease Connection:** Aging and cellular senescence, Cardiovascular disease (atherosclerosis, endothelial dysfunction), Metabolic disorders (diabetes, obesity), Cancer (context-dependent tumor suppressor), Neurodegenerative diseases, Osteoarthritis, Intervertebral disc degeneration

## 32. RECQL4 Knockout Reveals Novel ER Stress-Proliferation Paradox: Mechanistic Link to Cancer Predisposition in DNA Repair Deficiency Syndromes

**Date:** December 11, 2024
**Confidence:** 85/100
**Novelty:** 90/100
**Gene:** RECQL4 (RecQ Like Helicase 4)
**Disease Connection:** Rothmund-Thomson Syndrome type 2 (RTS2) - 32% osteosarcoma risk, RAPADILINO Syndrome, Baller-Gerold Syndrome

## 33. HSPA5 Knockout Reveals ER Stress-Mediated Mitochondrial Dysfunction and Apoptosis: Morphological Validation of Cancer Therapeutic Target

**Date:** December 11, 2025
**Confidence:** 82/100
**Novelty:** 70/100
**Gene:** HSPA5 (Heat Shock Protein Family A Member 5, BiP, GRP78)
**Disease Connection:** Multiple cancers (glioblastoma, liver, kidney - unfavorable prognosis), Neurodegeneration (Alzheimer's, Parkinson's, ALS, Huntington's)

## 34. VHL Loss Induces Metabolic Reprogramming with Severe Mitochondrial Dysfunction and Cellular Compaction

**Date:** December 11, 2025
**Confidence:** 88/100
**Novelty:** 75/100
**Gene:** VHL (Von Hippel-Lindau tumor suppressor)
**Disease Connection:** Clear cell renal cell carcinoma (ccRCC - >90% have VHL mutations), Von Hippel-Lindau syndrome, Congenital polycythemia, Malignant paraganglioma

## 35. TH Knockout Induces Compensatory Mitochondrial Biogenesis: A Novel Cellular Response to Dopamine Deficiency in Parkinson's Disease

**Date:** December 11, 2025
**Confidence:** 85/100
**Novelty:** 88/100
**Gene:** TH (Tyrosine Hydroxylase)
**Disease Connection:** Parkinson's Disease (dopaminergic neuron loss), Dopa-responsive dystonia, Segawa syndrome

## 36. NOTCH2 Knockout Induces Dramatic Cell Spreading Through Dysregulation of Focal Adhesion Dynamics

**Date:** December 12, 2024
**Confidence:** 85/100
**Novelty:** 88/100
**Gene:** NOTCH2 (Notch Receptor 2)
**Disease Connection:** Alagille Syndrome (ALGS2 - hepatic bile duct paucity, cardiovascular malformations), Hajdu-Cheney Syndrome (HJCYS - acro-osteolysis, osteoporosis)

## 37. Death Receptor Pathway Components Exhibit Constitutive Anti-Proliferative Functions Independent of Ligand Stimulation

**Date:** December 12, 2024
**Confidence:** 92/100
**Novelty:** 88/100
**Genes:** CASP8 (Caspase-8), TNFRSF10B (TRAIL-R2/DR5), FADD (Fas-Associated Death Domain)
**Disease Connection:** Head and neck squamous cell carcinoma (HNSCC), Hepatocellular carcinoma (HCC), Multiple cancers with CASP8/TNFRSF10B mutations, Immunotherapy response prediction
**Key Finding:** CASP8 and TNFRSF10B knockout leads to 11-fold increase in cell density, revealing constitutive growth suppression function independent of death ligand stimulation. Overexpression produces minimal effects (0.96-1.45x), indicating pathway saturation. This paradigm-shifting discovery explains why death receptor pathway mutations are frequent in cancer and provides mechanistic basis for immunotherapy biomarkers.

## 38. TIMP3 Perturbation Reveals Bidirectional ECM-Mitochondrial Crosstalk: A Novel Cellular Mechanism Underlying Sorsby Fundus Dystrophy and Cancer Progression

**Date:** December 12, 2024
**Confidence:** 86/100
**Novelty:** 80/100
**Gene:** TIMP3 (Tissue Inhibitor of Metalloproteinases 3)
**Disease Connection:** Sorsby Fundus Dystrophy (SFD - early-onset macular degeneration), Age-related Macular Degeneration (AMD), Multiple Cancers (kidney, liver, lung, colorectal, breast, glioblastoma - tumor suppressor frequently silenced)
**Key Finding:** TIMP3 knockout induces DNA damage (+7.34 texture variance) and mitochondrial redistribution (+8.70 radial distribution), while overexpression causes dramatic cellular enlargement (+35% area, p<10⁻¹¹), severe mitochondrial dysfunction (-33% intensity, p<10⁻³³), and nucleolar stress (+2.98 RNA granularity). This reveals a novel ECM-mitochondrial crosstalk axis where both loss and gain of TIMP3 function disrupt mitochondrial homeostasis through different mechanisms (redistribution vs. depletion), providing the first morphological evidence linking ECM dysregulation to intracellular organelle dysfunction and explaining cellular pathology in SFD beyond ECM accumulation.

## 39. ITGAV Knockout Disrupts Focal Adhesion Dynamics and Reveals Novel Therapeutic Vulnerability in Glioblastoma

**Date:** December 12, 2024
**Confidence:** 82/100
**Novelty:** 75/100
**Gene:** ITGAV (Integrin Alpha V)
**Disease Connection:** Glioblastoma (GBM - highly invasive brain tumor), Multiple cancers (promotes invasion and angiogenesis), Anti-integrin therapy target (cilengitide clinical trials)
**Key Finding:** ITGAV knockout induces compensatory cell spreading (1.73x area increase, p<0.001), enhanced actin polymerization (1.63x texture), and dramatic mitochondrial redistribution (2.11x texture - largest effect). Strong morphological similarity to ITGB5 knockout (0.67 cosine similarity) validates the αVβ5 heterodimer partnership. The paradoxical spreading phenotype suggests compensatory integrin switching and dysregulated focal adhesion dynamics. Novel discovery of mitochondrial redistribution as integrin signaling readout provides morphological biomarkers for anti-integrin therapy response and suggests combination strategies targeting both adhesion and metabolism. Explains cilengitide trial limitations and provides mechanistic basis for improved therapeutic approaches.

